{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-126074","form_type":"8-K","ticker":"BDTX","cik":"0001701541","company_name":"Black Diamond Therapeutics, Inc.","filed_at":"2022-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.754508+00:00","generated_at":"2026-06-21T06:13:11.596875+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Black Diamond Therapeutics spins out Launchpad Therapeutics with $30M Series A from Versant and NEA","bullets":["Spinout of Launchpad, an antibody-focused precision oncology company; $30M Series A led by Versant Ventures and NEA.","Black Diamond contributed undisclosed early-stage antibody programs and licensed its MAP Drug Discovery Engine to Launchpad.","Black Diamond received 9.0 million shares of Launchpad common stock (minority stake) for the contributed assets and license.","Black Diamond will continue focus on BDTX-1535, BDTX-4933, and small molecule pipeline while retaining upside via equity stake.","Launchpad will use the MAP Engine for large molecule discovery and development of novel antibody therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-126074","json":"https://secwatch.observer/filing/0001104659-22-126074.json","markdown":"https://secwatch.observer/filing/0001104659-22-126074.md","text":"https://secwatch.observer/filing/0001104659-22-126074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1701541/000110465922126074/0001104659-22-126074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1701541/000110465922126074/tm2232368d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T06:13:11.596875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}